Platelet Protein Kinase C-θ Deficiency With Human RUNX1 Mutation PRKCQ Is a Transcriptional Target of RUNX1
Platelet Protein Kinase C-θ Deficiency With Human RUNX1 Mutation PRKCQ Is a Transcriptional Target of RUNX1
复制标题
DOI:
10.1161/atvbaha.110.221879
复制
发表时间:
2011-04-01
影响因子:
8.7
通讯作者:
Rao, A. Koneti
中科院分区:
文献类型:
--
作者:
Jalagadugula, Gauthami;Mao, Guangfen;Rao, A. Koneti
Objective-Mutations in the hematopoietic transcription factor RUNX1 cause thrombocytopenia and impaired platelet function. In a patient with a heterozygous mutation in RUNX1, we have described decreased platelet pleckstrin phosphorylation and protein kinase C-theta (PKC-theta, gene PRKCQ) associated with thrombocytopenia, impaired platelet aggregation, and dense granule secretion. Little is known regarding regulation of PKC-theta in megakaryocytes and platelets. We have addressed the hypothesis that PRKCQ is a direct transcriptional target of RUNX1.Methods and Results-In a chromatin immunoprecipitation assay using megakaryocytic cells, there was RUNX1 binding in vivo to PRKCQ promoter region -1225 to -1056 bp containing a RUNX1 consensus site ACCGCA at -1088 to -1069 bp; an electrophoretic mobility shift assay showed RUNX1 binding to the specific site. In RUNX1 overexpression studies, PKC-theta protein expression and promoter activity were enhanced; mutation of RUNX1 site showed decreased activity even with RUNX1 overexpression. Lastly, PRKCQ promoter activity and PKC-theta protein were decreased by short interfering RNA knockdown of RUNX1.Conclusion-Our results provide the first evidence that PRKCQ is regulated at the transcriptional level by RUNX1 in megakaryocytic cells and a mechanism for PKC-theta deficiency associated with RUNX1 haplodeficiency. (Arterioscler Thromb Vasc Biol. 2011;31:921-927.)